Avitar to market saliva collection system for DNA testing.WALLINGFORD, Conn.--(BUSINESS WIRE)--December 5, 1996--Avitar, Inc. (Nasdaq SmallCap Market:AVIT AVIT Aarupadai Veedu Institute of Technology AVIT Audiovisual Instructional Technology (Common Stock); AVITW (Redeemable Warrants)) announced today that it has begun to market a version of its saliva collection system specifically for use in the DNA testing DNA testing Analysis of DNA (the genetic component of cells) in order to determine changes in genes that may indicate a specific disorder. Mentioned in: Acoustic Neuroma, Retinoblastoma, Von Willebrand Disease market. The system will be sold for use as a component in the performance of DNA amplification DNA amplification Molecular diagnostics Any method used to ↑ the copy number of a sequence of DNA. See Cycling probe technology, Gap LCR–gap ligase chain reaction, Gene amplification, NASBA–nucleic acid sequence-based amplification, PCR, techniques such as PCR PCR polymerase chain reaction. PCR abbr. polymerase chain reaction Polymerase chain reaction (PCR) , as well as others. These DNA tests are used for the determination of paternity, the detection of genetic disorders, the detection of infectious diseases, and forensics. Peter Phildius, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Avitar, commented, "This expansion of our sample collection technology into the DNA testing market is exciting. Early feedback from prospective customers indicates that they believe the product has advantages over existing methods and is more cost-effective. The dramatic growth in this field in recent years offers Avitar a significant market opportunity. This, combined with our previously-announced entry into the non-invasive diagnostic testing Diagnostic testing Testing performed to determine if someone is affected with a particular disease. Mentioned in: Von Willebrand Disease market, positions Avitar to leverage its technology in this rapidly-growing segment of the medical market." Avitar, Inc. designs, develops, manufactures and markets healthcare products and services including Hydrasorb(TM), a proprietary line of polyurethane wound care dressings. The Company also provides healthcare cost containment services to employers and third-party payers. CONTACT: AVITAR, INC. Peter Phildius, 617/821-2440 Jay Leatherman, 203/265-3594 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion